Home LiteratureArticle Details
PMID: 3397178 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5.

Infection and immunity ·Vol. 56 ·No. 8 ·1988-08-00 ·Pages 1880-9

Inzana TJ, Ma J, Workman T, Gogolewski RP, Anderson P

Abstract

The role of the capsule of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5 in bacterial virulence, and the protective efficacy of antibody to serotype 5 capsule was investigated. Encapsulated H. pleuropneumoniae serotype 5 were resistant to killing by complement and antibody to capsule or somatic antigens, whereas a noncapsulated mutant was sensitive to killing by the alternative complement pathway alone. Antiserum to whole H. pleuropneumoniae serotype 5 bacteria or monospecific antiserum to capsule was capable of opsonizing bacteria of the homologous serotype for phagocytosis by swine polymorphonuclear leukocytes but was not opsonic for a heterologous serotype. An immunoglobulin M monoclonal antibody to the serotype 5 capsule was not opsonic for any serotype. Mice were protected against lethal, intranasal challenge with the homologous or heterologous serotype after immunization with live encapsulated or noncapsulated bacteria, but not after immunization with killed bacteria, lipopolysaccharide, or a capsule-protein conjugate vaccine. The protection induced by immunization with live bacteria was transferred to nonimmune, syngeneic mice by serum but not by spleen cells. Nonimmune pigs passively immunized with monospecific swine serum to capsule were protected from lethal infection but not from development of hemorrhagic lung lesions, whereas pigs passively immunized with swine antiserum to live bacteria did not develop severe respiratory lesions. Thus, the capsule of H. pleuropneumoniae serotype 5 was inhibitory to the bactericidal activity of serum and was antiphagocytic. Antibody to the capsule was opsonic but was not fully protective.

MeSH Terms
Animals Antibodies, Bacterial/immunology Antigens, Bacterial/immunology Complement System Proteins/physiology Dose-Response Relationship, Immunologic Haemophilus/immunology,pathogenicity Immunization Immunization, Passive Mycoplasma Infections/veterinary Neutrophils/physiology Phagocytosis Pleuropneumonia, Contagious/microbiology,prevention & control Polysaccharides, Bacterial/physiology Swine Swine Diseases/microbiology
Chemicals
Antibodies, Bacterial Antigens, Bacterial Polysaccharides, Bacterial Complement System Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Inzana T J
Department of Veterinary Microbiology-Pathology, Washington State University, Pullman 99164-7040.
Ma J
Workman T
Gogolewski R P
Anderson P
References (38)
38 references, click to expand
  1. Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae.
    Infect Immun. 1986 Sep;53(3):474-9 PMID: 3527983
  2. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    J Clin Invest. 1980 Jan;65(1):82-94 PMID: 6985617
  3. Haemophilus pleuropneumoniae serotypes--cross protection experiments.
    Nord Vet Med. 1984 Jul-Aug;36(7-8):221-34 PMID: 6493974
  4. Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae.
    Can Vet J. 1985 Feb;26(2):86-9 PMID: 17422508
  5. Studies on immunity to Haemophilus pleuropneumoniae infections in mice.
    Am J Vet Res. 1982 Oct;43(10):1793-8 PMID: 7149378
  6. Phagocytosis of microorganisms.
    Rev Infect Dis. 1982 Jan-Feb;4(1):104-23 PMID: 6122253
  7. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.
    J Exp Med. 1944 Feb 1;79(2):137-58 PMID: 19871359
  8. Growth and hemolysin production by Haemophilus pleuropneumoniae cultivated in a chemically defined medium.
    Can J Microbiol. 1986 Oct;32(10):801-5 PMID: 3791049
  9. Haemophilus parahaemolyticus serotypes. Pathogenicity and cross immunity.
    Nord Vet Med. 1979 Oct;31(10):407-13 PMID: 392450
  10. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
    Pediatr Res. 1987 Dec;22(6):659-66 PMID: 3324033
  11. Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.
    Infect Immun. 1987 Jul;55(7):1573-9 PMID: 3596801
  12. Pleuropneumonia of swine caused by Haemophilus parahaemolyticus. Studies on the protection obtained by vaccination.
    Nord Vet Med. 1976 Jul-Aug;28(7-8):337-48 PMID: 958865
  13. Surface determinants of Haemophilus influenzae pathogenicity: comparative virulence of capsular transformants in normal and complement-depleted rats.
    J Infect Dis. 1983 Sep;148(3):385-94 PMID: 6604759
  14. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
    J Immunol. 1979 Oct;123(4):1839-46 PMID: 573303
  15. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.
    Infect Immun. 1986 Aug;53(2):298-304 PMID: 3525407
  16. Role of immunity in the clearance of bacteremia due to Haemophilus influenzae.
    J Infect Dis. 1978 Oct;138(4):427-36 PMID: 309494
  17. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
    Microbiol Rev. 1983 Mar;47(1):46-83 PMID: 6343827
  18. Cloning of chromosomal DNA from Haemophilus influenzae. Its use for studying the expression of type b capsule and virulence.
    J Clin Invest. 1984 Feb;73(2):298-306 PMID: 6607932
  19. Protective efficacy of capsule extracts of Haemophilus pleuropneumoniae in pigs and mice.
    Vet Microbiol. 1986 Sep;12(3):229-40 PMID: 3776093
  20. SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.
    Science. 1964 Aug 14;145(3633):709-10 PMID: 14168277
  21. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
    J Infect Dis. 1986 Jan;153(1):8-16 PMID: 3484506
  22. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.
    Immunochemistry. 1978 Nov;15(10-11):839-54 PMID: 372096
  23. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
    J Exp Med. 1980 Aug 1;152(2):361-76 PMID: 6967514
  24. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.
    J Infect Dis. 1981 Apr;143(4):517-24 PMID: 6972419
  25. Generation of chemotactic activity in serum by Haemophilus influenzae type b.
    Infect Immun. 1984 Feb;43(2):593-9 PMID: 6607218
  26. A new oral vaccine against typhoid fever.
    J Infect Dis. 1982 Mar;145(3):289-91 PMID: 7037981
  27. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
    Infect Immun. 1987 Nov;55(11):2662-8 PMID: 3312006
  28. Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.
    Infect Immun. 1973 Sep;8(3):488-90 PMID: 4542337
  29. Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis.
    Am J Vet Res. 1985 Feb;46(2):342-7 PMID: 3888006
  30. Serum bactericidal effect on capsulated and non-capsulated Haemophilus influenzae.
    Acta Pathol Microbiol Scand C. 1980 Feb;88(1):47-56 PMID: 6966461
  31. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Infect Immun. 1987 Jul;55(7):1668-73 PMID: 3298063
  32. Haemophilus pleuropneumoniae infection in swine: a review.
    J Am Vet Med Assoc. 1983 Jun 15;182(12):1331-7 PMID: 6348003
  33. Bacterial capsule--old dogmas and new tricks.
    J Infect Dis. 1986 Mar;153(3):407-15 PMID: 2419454
  34. Immune responses to the lipopolysaccharides and capsular polysaccharides of Haemophilus pleuropneumoniae in convalescent and immunized pigs.
    Infect Immun. 1986 Nov;54(2):575-82 PMID: 3490442
  35. Serum factor-dependent resistance of Haemophilus influenzae type b to antibody to lipopolysaccharide.
    J Infect Dis. 1985 May;151(5):869-77 PMID: 2580914
  36. Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.
    Infect Immun. 1987 Jul;55(7):1580-7 PMID: 3110066
  37. Vaccination: Is it Effective in Preventing Respiratory Disease or Influencing Weight Gains in Feedlot Calves?
    Can Vet J. 1983 Jan;24(1):10-9 PMID: 17422213
  38. The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents.
    Biochemistry. 1969 Oct;8(10):4074-82 PMID: 5388146
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1988-08-00
Pages
1880-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259496
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]